Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Gastroenterology. 2021 Nov 13;162(3):828–843.e11. doi: 10.1053/j.gastro.2021.11.015

Figure 1. Summary of the study workflow.

Figure 1.

A) An overview of the number of samples and metabolites detected in serum and stool of the MSCCR. B) The metabolite GWAS design. C) Flow chart summarizing the integration of genotype and metabolite information available from the present MSSCR cohort and publicly available IBD meta-analysis11, in order to assess a causal relationship between metabolite changes and IBD.